Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 13/20 | 0.54 |
| ▸ | CA1 | P00915 | 13/20 | 0.54 |
| ▸ | CA2 | P00918 | 13/20 | 0.54 |
| ▸ | CA4 | P22748 | 10/20 | 0.54 |
| ▸ | CA5A | P35218 | 10/20 | 0.54 |
| ▸ | CA7 | P43166 | 10/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 10/20 | 0.54 |
| ▸ | CA9 | Q16790 | 7/20 | 0.52 |
| ▸ | CA6 | P23280 | 4/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 4/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | P4HB | P07237 | 1/20 | 0.50 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.50 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12762931 | 0.82 | TSHR (1.00) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL4368202 | 0.82 | TSHR (0.64) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL8101493 | 0.80 | TSHR (0.61) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL14009724 | 0.80 | TSHR (0.81) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL14036045 | 0.80 | TSHR (0.81) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL25088449 | 0.80 | TSHR (0.75) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL15284474 | 0.80 | TSHR (0.75) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL15269669 | 0.80 | TSHR (0.75) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL15284473 | 0.80 | TSHR (0.75) | TSHRPTPN1CA12CA1CA2 | |
| SCHEMBL4810892 | 0.79 | TSHR (0.67) | TSHRPTPN1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622563-B2 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20050272921-A1 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1544207-A1 | PROCESS FOR PRODUCING GLYCOSIDE | Mitsui Chemicals, Inc. (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272921-A1 | Process for producing glycoside | HAAO, OGA, MGAM | TSHR 3613/4885PTPN1 3456/4885CA12 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.